XML 30 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Basis of Presentation (Tables)
6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Schedule of cash, cash equivalents, and restricted cash
The following table provides a reconciliation of cash, cash equivalents, and restricted cash as reported within the Unaudited Condensed Consolidated Balance Sheets to “Cash, cash equivalents, and restricted cash at end of period” as reported within the Unaudited Condensed Consolidated Statements of Cash Flows:
Successor
In thousandsJune 30, 2021December 31, 2020
Cash and cash equivalents$13,565 $518 
Restricted cash, current— 1,000 
Restricted cash included in other assets46,200 40,730 
Total cash, cash equivalents, and restricted cash shown in the Unaudited Condensed Consolidated Statements of Cash Flows$59,765 $42,248 
Schedule of earnings per share, basic and diluted reconciliation
The following is a reconciliation of the weighted average shares used in the basic and diluted net loss per common share calculations for the periods indicated:
SuccessorPredecessorSuccessorPredecessor
In thousandsThree Months Ended
June 30, 2021
Three Months Ended
June 30, 2020
Six Months Ended
June 30, 2021
Six Months Ended
June 30, 2020
Weighted average common shares outstanding – basic50,999 495,245 50,661 494,752 
Effect of potentially dilutive securities
Restricted stock units— — — 
Warrants— — — — 
Restricted stock and performance-based equity awards— — — — 
Convertible senior notes(1)
— — — — 
Weighted average common shares outstanding – diluted(2)
50,999 495,245 50,661 494,752 

(1)In connection with the Company’s emergence from bankruptcy on September 18, 2020, all outstanding convertible senior notes were fully extinguished.
(2)If the Company had recognized net income, the weighted average diluted shares outstanding would have been 54.3 million and 587.1 million for the three months ended June 30, 2021 and 2020, respectively, and 52.7 million and 586.6 million for the six months ended June 30, 2021 and 2020, respectively.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following outstanding securities were excluded from the computation of diluted net loss per share, as their effect would have been antidilutive, as of the respective dates:
SuccessorPredecessor
In thousandsJune 30, 2021June 30, 2020
Restricted stock units1,255 — 
Warrants5,503 — 
Stock appreciation rights— 1,493 
Nonvested time-based restricted stock and performance-based equity awards— 5,572 
Convertible senior notes— 83,495